Michael K Driver, MD
Emergency Medicine · Richland
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 46 years
- Graduated 1980
Offices
1 location · Health First Urgent Care, PLLC · 14 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office at (509) 300-1500 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MD.MD.00025405Physician And Surgeon License · since 1988 · expires 2027-01-27ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Original Medicare doctor bills
$50,800
Medicare paid this office $50,800 for 296 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Detection test by nucleic acid for organism, amplified probe technique | 65 | $16,300 | $34 |
| Short return visit (20+ min) | 155 | $11,281 | $64 |
| New patient visit (30+ min) | 104 | $6,156 | $59 |
| Detection test for candida species (yeast), amplified probe technique | 20 | $2,785 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 57 | $2,029 | $34 |
See all 14 services
| Detection test by nucleic acid for organism, amplified probe technique | 65 | $16,300 | $34 |
| Short return visit (20+ min) | 155 | $11,281 | $64 |
| New patient visit (30+ min) | 104 | $6,156 | $59 |
| Detection test for candida species (yeast), amplified probe technique | 20 | $2,785 | $34 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 57 | $2,029 | $34 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 47 | $1,616 | $34 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 47 | $1,616 | $34 |
| Return visit (30+ min) | 14 | $1,319 | $88 |
| New patient visit (45+ min) | 15 | $1,317 | $88 |
| Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique | 36 | $1,238 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 28 | $963 | $34 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 13 | $447 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 13 | $447 | $34 |
| Automated urinalysis test | 29 | $66 | $2 |
Who their Medicare patients are
296 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 13% · Women 60% · Also on Medicaid 12% · Health risk score 1.17. At or below the middle of the specialty; the typical emergency medicine clinician is at 2.01.
Conditions among them: High blood pressure 61% · Diabetes 27% · Depression 22% · Chronic kidney disease 21% · Coronary heart disease 18% · Cancer 17% · COPD 17% · Atrial fibrillation 15% · Heart failure 11% · Dementia 8% · Stroke 7%.
The office billed $124,426, Medicare allowed $64,042 and paid $50,800; for 1,243 services of 51 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 296 | 1,243 | 73 | 1.17 | $124,426 | $50,800 |
| 2023 | 291 | 1,497 | 73 | 1.14 | $143,947 | $64,330 |
| 2022 | 117 | 409 | 73 | 1.13 | $93,075 | $22,616 |
| 2021 | 173 | 259 | 73 | 1.57 | $245,829 | $20,156 |
| 2020 | 55 | 67 | 73 | 2.44 | $93,292 | $6,818 |
| 2019 | 84 | 100 | 71 | 2.13 | $123,186 | $8,562 |
| 2018 | 124 | 150 | 72 | 1.77 | $194,533 | $13,198 |
| 2017 | 51 | 55 | 69 | 2.58 | $78,973 | $5,658 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Detection test by nucleic acid for organism, amplified probe technique | 78 | $22,559 | $34 |
| Short return visit (20+ min) | 145 | $10,048 | $65 |
| New patient visit (30+ min) | 127 | $9,551 | $75 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 70 | $2,510 | $34 |
| Detection test for candida species (yeast), amplified probe technique | 28 | $2,338 | $34 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 16 | $2,236 | $140 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 49 | $1,720 | $34 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 49 | $1,720 | $34 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 23 | $1,691 | $74 |
| Return visit (30+ min) | 14 | $1,451 | $104 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 33 | $1,169 | $34 |
| Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique | 25 | $860 | $34 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 19 | $653 | $34 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 23 | $564 | $25 |
| Automated urinalysis test | 21 | $51 | $2 |
2022: 10 services
| Detection test by nucleic acid for organism, amplified probe technique | 17 | $4,918 | $34 |
| New patient visit (30+ min) | 43 | $3,477 | $81 |
| Emergency department visit with high level of medical decision making | 12 | $1,967 | $151 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 13 | $1,817 | $140 |
| Short return visit (20+ min) | 22 | $1,686 | $77 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 16 | $1,176 | $74 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 17 | $585 | $34 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 13 | $447 | $34 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 13 | $447 | $34 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 16 | $392 | $25 |
2021: 6 services
| Emergency department visit with high level of medical decision making | 51 | $7,378 | $139 |
| Emergency department visit with moderate level of medical decision making | 37 | $3,114 | $82 |
| Emergency department visit with low level of medical decision making | 34 | $1,679 | $47 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,679 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,165 | $83 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 31 | $203 | $6 |
2020: 2 services
| Emergency department visit with high level of medical decision making | 33 | $4,716 | $131 |
| Emergency department visit with moderate level of medical decision making | 15 | $1,577 | $93 |
2019: 3 services
| Emergency department visit with high level of medical decision making | 39 | $5,193 | $130 |
| Emergency department visit with moderate level of medical decision making | 18 | $1,654 | $92 |
| Emergency department visit with low level of medical decision making | 24 | $1,163 | $48 |
2018: 4 services
| Emergency department visit with high level of medical decision making | 67 | $8,886 | $131 |
| Emergency department visit with low level of medical decision making | 40 | $1,868 | $44 |
| Emergency department visit with moderate level of medical decision making | 18 | $1,855 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $80 | $7 |
2017: 2 services
| Emergency department visit with high level of medical decision making | 31 | $4,175 | $135 |
| Emergency department visit with low level of medical decision making | 11 | $577 | $48 |
Medicaid work
$236,213 in 2024
Medicaid paid $236,213 for 3,515 billed services this clinician did in 2024, up to 113 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 1,224 | $76,331 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 381 | $49,482 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 321 | $40,296 |
| New patient visit (30+ min) | 440 | $34,979 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 147 | $17,082 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 43 | $3,775 |
| Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique | 151 | $3,340 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 109 | $3,189 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe technique | 95 | $2,461 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 147 | $2,299 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 147 | $2,287 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 25 | $333 |
| 2024 | 3,515 | 15 | 113 | $236,213 |
| 2023 | 5,519 | 19 | 146 | $365,236 |
| 2022 | 2,183 | 20 | 193 | $142,951 |
| 2021 | 1,420 | 3 | 85 | $75,625 |
| 2020 | 719 | 5 | 45 | $38,382 |
| 2019 | 1,032 | 7 | 78 | $56,928 |
| 2018 | 1,164 | 7 | 84 | $68,709 |
See the largest Medicaid services in earlier years
2023
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 580 | $99,150 |
| Short return visit (20+ min) | 1,392 | $80,623 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 273 | $67,128 |
| New patient visit (30+ min) | 638 | $47,484 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 170 | $22,275 |
| Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique | 371 | $9,969 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 341 | $9,025 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 341 | $8,993 |
| Infectious agent detection by nucleic acid (DNA or RNA); Candida species, amplified probe technique | 80 | $6,663 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 85 | $5,430 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, amplified probe technique | 136 | $3,821 |
| Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe technique | 122 | $3,138 |
2022
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 12-25 targets | 100 | $33,571 |
| Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism | 159 | $30,580 |
| New patient visit (30+ min) | 263 | $20,353 |
| EMERGENCY DEPT VISIT LOW MDM | 279 | $13,629 |
| Short return visit (20+ min) | 203 | $13,536 |
| EMERGENCY DEPT VISIT MOD MDM | 76 | $5,970 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 44 | $3,998 |
| Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique | 147 | $3,953 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia pneumoniae, amplified probe technique | 138 | $3,734 |
| Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, amplified probe technique | 138 | $3,702 |
| Infectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or sub-types, includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, first 2 types or sub-types | 41 | $3,075 |
| Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when performed, and multiplex amplified probe technique, multiple types or subtypes, 3-5 targets | 30 | $2,435 |
2021
| EMERGENCY DEPT VISIT LOW MDM | 744 | $29,288 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 319 | $26,694 |
| EMERGENCY DEPT VISIT MOD MDM | 357 | $19,643 |
2020
| EMERGENCY DEPT VISIT LOW MDM | 468 | $24,035 |
| EMERGENCY DEPT VISIT MOD MDM | 195 | $14,208 |
| COMPREHENSIVE METABOLIC PANEL | 20 | $69 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 21 | $56 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 15 | $14 |
2019
| EMERGENCY DEPT VISIT LOW MDM | 688 | $30,551 |
| EMERGENCY DEPT VISIT MOD MDM | 259 | $24,062 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 18 | $1,773 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 12 | $331 |
| COMPREHENSIVE METABOLIC PANEL | 20 | $107 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 20 | $79 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 15 | $26 |
2018
| EMERGENCY DEPT VISIT LOW MDM | 761 | $48,265 |
| EMERGENCY DEPT VISIT MOD MDM | 272 | $18,496 |
| EMERGENCY DEPARTMENT VISIT HIGH MDM | 13 | $1,131 |
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 16 | $409 |
| COMPREHENSIVE METABOLIC PANEL | 36 | $201 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 37 | $154 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 29 | $52 |
Drugs they prescribed that Part D paid
$3,236
Pharmacies billed $3,236 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (15 of 357) in 2024. At or below the middle of the specialty; the typical emergency medicine clinician is at 12%.
325 generic and 32 brand-name prescriptions · $3,236 in drug cost · 201 antibiotic prescriptions to 165 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 59 | $561 | $9 |
| Nitrofurantoin Mono-Macro | 26 | $344 | $13 |
| Cephalexin | 22 | $286 | $13 |
| Albuterol Sulfate Hfa | 16 | $284 | $18 |
| Ondansetron Odt | 11 | $147 | $13 |
See all 11 drugs
| Amoxicillin-Clavulanate Potass | 59 | $561 | $9 |
| Nitrofurantoin Mono-Macro | 26 | $344 | $13 |
| Cephalexin | 22 | $286 | $13 |
| Albuterol Sulfate Hfa | 16 | $284 | $18 |
| Ondansetron Odt | 11 | $147 | $13 |
| Ofloxacin | 12 | $124 | $10 |
| Ciprofloxacin | 17 | $120 | $7 |
| Sulfamethoxazole-Trimethoprim | 21 | $116 | $6 |
| Azithromycin | 26 | $102 | $4 |
| Clindamycin | 14 | $89 | $6 |
| Prednisone | 21 | $55 | $2 |
Year by year
| 2024 | 357 | 242 | 4% (15) | 9% | $3,236 |
| 2023 | 398 | 240 | 4% (17) | None | $4,699 |
| 2022 | 222 | 134 | 14% (32) | None | $2,194 |
| 2021 | 314 | 200 | 20% (64) | 7% | $4,505 |
| 2020 | 377 | 255 | 21% (78) | 5% | $5,477 |
| 2019 | 439 | 303 | 24% (106) | 5% | $6,771 |
| 2018 | 391 | 283 | 19% (74) | None | $4,227 |
| 2017 | 411 | 294 | 21% (85) | None | $4,123 |
| 2016 | 396 | 272 | 24% (96) | 6% | $3,250 |
| 2015 | 367 | 271 | 23% (85) | 11% | $5,963 |
| 2014 | 376 | 254 | 21% (78) | None | $6,553 |
| 2013 | 339 | 214 | 19% (63) | None | $5,694 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Nitrofurantoin Mono-Macro | 29 | $536 | $18 |
| Amoxicillin-Clavulanate Potass | 42 | $509 | $12 |
| Cephalexin | 42 | $468 | $11 |
| Azithromycin | 42 | $219 | $5 |
| Sulfamethoxazole-Trimethoprim | 38 | $162 | $4 |
| Mupirocin | 15 | $161 | $11 |
| Clindamycin | 13 | $74 | $6 |
| Hydrocodone-Acetaminophen | 13 | $66 | $5 |
| Prednisone | 19 | $57 | $3 |
| Ciprofloxacin | 11 | $57 | $5 |
2022: 5 drugs
| Nitrofurantoin Mono-Macro | 15 | $279 | $19 |
| Ondansetron Odt | 18 | $211 | $12 |
| Azithromycin | 22 | $136 | $6 |
| Hydrocodone-Acetaminophen | 24 | $82 | $3 |
| Prednisone | 18 | $47 | $3 |
2021: 7 drugs
| Nitrofurantoin Mono-Macro | 43 | $866 | $20 |
| Cephalexin | 20 | $233 | $12 |
| Hydrocodone-Acetaminophen | 50 | $228 | $5 |
| Sulfamethoxazole-Trimethoprim | 26 | $141 | $5 |
| Ondansetron Odt | 15 | $107 | $7 |
| Azithromycin | 14 | $58 | $4 |
| Prednisone | 13 | $51 | $4 |
2020: 13 drugs
| Nitrofurantoin Mono-Macro | 29 | $619 | $21 |
| Doxycycline Hyclate | 27 | $325 | $12 |
| Hydrocodone-Acetaminophen | 66 | $256 | $4 |
| Ondansetron Odt | 23 | $200 | $9 |
| Clindamycin | 13 | $145 | $11 |
| Sulfamethoxazole-Trimethoprim | 27 | $134 | $5 |
| Prednisone | 23 | $113 | $5 |
| Cephalexin | 17 | $105 | $6 |
| Metronidazole | 11 | $103 | $9 |
| Azithromycin | 13 | $91 | $7 |
| Ciprofloxacin | 16 | $79 | $5 |
| Cyclobenzaprine | 15 | $74 | $5 |
| Amoxicillin | 13 | $63 | $5 |
2019: 15 drugs
| Nitrofurantoin Mono-Macro | 23 | $494 | $21 |
| Hydrocodone-Acetaminophen | 73 | $307 | $4 |
| Doxycycline Hyclate | 12 | $278 | $23 |
| Ciprofloxacin | 33 | $258 | $8 |
| Ondansetron Odt | 28 | $240 | $9 |
| Azithromycin | 36 | $227 | $6 |
| Clindamycin | 15 | $187 | $12 |
| Metronidazole | 14 | $185 | $13 |
| Prednisone | 27 | $137 | $5 |
| Cephalexin | 16 | $99 | $6 |
| Amoxicillin-Clavulanate Potass | 12 | $92 | $8 |
| Levofloxacin | 13 | $80 | $6 |
| Cyclobenzaprine | 18 | $70 | $4 |
| Oxycodone | 11 | $60 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $40 | $4 |
2018: 9 drugs
| Clindamycin | 32 | $345 | $11 |
| Ciprofloxacin | 41 | $296 | $7 |
| Doxycycline Hyclate | 15 | $269 | $18 |
| Hydrocodone-Acetaminophen | 55 | $257 | $5 |
| Azithromycin | 41 | $204 | $5 |
| Ondansetron Odt | 28 | $152 | $5 |
| Amoxicillin-Clavulanate Potass | 12 | $141 | $12 |
| Prednisone | 24 | $120 | $5 |
| Levofloxacin | 13 | $80 | $6 |
2017: 7 drugs
| Azithromycin | 66 | $354 | $5 |
| Hydrocodone-Acetaminophen | 66 | $324 | $5 |
| Ciprofloxacin | 53 | $293 | $6 |
| Clindamycin | 19 | $224 | $12 |
| Levofloxacin | 19 | $161 | $8 |
| Ondansetron Odt | 29 | $148 | $5 |
| Prednisone | 32 | $146 | $5 |
2016: 11 drugs
| Hydrocodone-Acetaminophen | 63 | $335 | $5 |
| Levofloxacin | 43 | $329 | $8 |
| Azithromycin | 54 | $298 | $6 |
| Ondansetron Odt | 30 | $224 | $7 |
| Metronidazole | 14 | $202 | $14 |
| Clindamycin | 16 | $201 | $13 |
| Ciprofloxacin | 23 | $173 | $8 |
| Prednisone | 22 | $115 | $5 |
| Cephalexin | 16 | $95 | $6 |
| Sulfamethoxazole-Trimethoprim | 17 | $59 | $3 |
| Hydromorphone | 11 | $43 | $4 |
2015: 9 drugs
| Azithromycin | 62 | $329 | $5 |
| Levofloxacin | 30 | $276 | $9 |
| Hydrocodone-Acetaminophen | 57 | $269 | $5 |
| Ciprofloxacin | 29 | $164 | $6 |
| Ondansetron Odt | 15 | $144 | $10 |
| Clindamycin | 16 | $142 | $9 |
| Prednisone | 25 | $110 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $100 | $8 |
| Cephalexin | 13 | $74 | $6 |
2014: 7 drugs
| Azithromycin | 49 | $328 | $7 |
| Ciprofloxacin | 57 | $309 | $5 |
| Hydrocodone-Acetaminophen | 54 | $303 | $6 |
| Clindamycin | 24 | $290 | $12 |
| Ondansetron | 18 | $153 | $9 |
| Prednisone | 23 | $118 | $5 |
| Cephalexin | 12 | $116 | $10 |
2013: 6 drugs
| Azithromycin | 55 | $490 | $9 |
| Ciprofloxacin | 51 | $343 | $7 |
| Hydrocodone-Acetaminophen | 36 | $155 | $4 |
| Cephalexin | 12 | $123 | $10 |
| Prednisone | 32 | $117 | $4 |
| Sulfamethoxazole-Trimethoprim | 12 | $82 | $7 |
Professional record
- NPI
- 1811033574
- Licence
- WA MD00025405Washington MD.MD.00025405: Active
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207P00000X (207P00000X)
- Mailing address
- Po Box 189, Clarkston, WA, 99403
- NPI first listed
- 2007-01-29
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.